FDA approves Olysio to treat chronic hepatitis C
The U.S. Food and Drug Administration yesterday approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Image/Video Screen Shot Hepatitis C is a viral disease that causes inflammation More...